KAO JOHN E 4

What Happened

• John E. Kao, CEO of Alignment Healthcare, sold 73,046 shares on 2026-03-18 in an open-market transaction. The weighted-average sale price was $17.84 per share for total proceeds of about $1,303,141. The per-share sales ranged from $17.40 to $18.24. This was a sale to cover tax withholding related to the vesting of restricted stock units, not a discretionary trade.

Key Details

• Transaction date: 2026-03-18 (reported on Form 4 filed 2026-03-19) — filing appears timely.
• Transaction type/code: Sale (S); weighted-average price $17.84; price range $17.40–$18.24.
• Shares sold: 73,046; gross proceeds ≈ $1,303,141.
• Shares owned after transaction: Not specified in the Form 4 filing.
• Notable footnotes:
  • F1: Sale represents shares sold to cover tax withholding on RSU vesting (not discretionary).
  • F2: Reported price is weighted-average; multiple trades occurred across the $17.40–$18.24 range. Full per-price breakdown available on request.
  • F3: Some securities are held by the JEK Trust (Mr. Kao is trustee).

Context

• This was a routine sell-to-cover following RSU vesting (a common practice for executives) and does not necessarily indicate a change in the CEO’s view of the company. Financially meaningful purchases tend to be more informative about insider conviction; this transaction was specifically for tax withholding.